Trial Profile
Prospective, Interventional, Randomized, Double-masked With the Use of Ganciclovir Gel 0.3% for Treatment of Conjunctivitis Caused by Adenovirus.
Status:
Not yet recruiting
Phase of Trial:
Phase III
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Ganciclovir (Primary)
- Indications Conjunctivitis
- Focus Therapeutic Use
- 22 May 2012 New trial record